Immunology
Study links monocyte “biological aging” in blood to emotional depression symptoms in women with and without HIV
An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya
A study of 440 participants from the Women’s Interagency HIV Study found that accelerated epigenetic aging in monocytes—an immune cell type—tracked more closely with emotional and cognitive depression symptoms such as hopelessness and loss of pleasure than with physical symptoms like fatigue. The work, published in The Journals of Gerontology: Series A, adds evidence that cell-type-specific aging measures could contribute to future biological tools to complement symptom-based depression screening, though researchers say more validation is needed before clinical use.
New technologies are allowing researchers to peer into the nanoscale workings of the human immune system. Immunologist Daniel Davis highlighted these advances at WIRED Health. The insights could transform approaches to diseases like cancer.
An Ruwaito ta hanyar AI
A 47-year-old woman bedridden with autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid syndrome has achieved complete remission after CAR-T cell therapy at University Hospital Erlangen in Germany. Treated by Fabian Müller after nine failed therapies, she recovered rapidly and remains healthy over a year later without medication—the first simultaneous treatment of multiple autoimmune diseases with this method.
A Texas A&M University team has developed a biodegradable microneedle patch that delivers interleukin‑4 directly to damaged heart tissue after a heart attack. In preclinical models, this targeted approach shifts immune cells into a healing mode and improves communication between heart muscle and blood vessel cells, while avoiding many of the side effects seen with systemic drug delivery.
An Ruwaito ta hanyar AI
Researchers have identified unusual microscopic structures in the blood of long COVID patients, consisting of microclots intertwined with neutrophil extracellular traps, or NETs. These formations are more frequent, larger, and denser in affected individuals compared to healthy controls. The findings suggest potential mechanisms behind long COVID's persistent symptoms and open doors to new diagnostics and treatments.
The 2025 Nobel prize in physiology or medicine has been awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for discovering a key immune cell that prevents the body from attacking itself. Their work revealed regulatory T-cells and the FOXP3 gene's role in controlling autoimmune responses. This breakthrough has opened new avenues for treating autoimmune diseases and cancers.
An Ruwaito ta hanyar AI
Researchers have discovered that glioblastoma, the most aggressive form of brain cancer, extends beyond the brain by eroding the skull and altering the immune cells in skull marrow. This interaction fuels the cancer's progression and explains why current treatments often fail. The findings, published in Nature Neuroscience, suggest new strategies targeting both brain and bone.
Study links a distinct CD14+ monocyte state to fatigue and breathing symptoms in long COVID
March 13, 2026 23:47Severe COVID or flu may raise lung cancer risk years later
February 10, 2026 17:36Neutrophils reprogrammed by tumors to produce cancer-promoting CCL3
January 30, 2026 15:40Decades after a small breast cancer vaccine trial, researchers link lasting immune memory to CD27
January 24, 2026 15:58Chemotherapy alters gut bacteria to block cancer metastasis
November 04, 2025 13:17AI and lab work reveal how a NOD2–girdin partnership restrains gut inflammation in Crohn's
October 30, 2025 08:22Electrical stimulation reprograms human immune cells to spur repair
October 20, 2025 00:10Breastfeeding boosts immune cells that may prevent breast cancer
October 16, 2025 00:49Next-generation mRNA vaccines aim for stronger immune responses
October 15, 2025 00:30Immune protein promotes arrhythmias after heart attacks